Wellness Resources News
Science-based natural health news to help you take charge of your health!
Our mission & writing commitmentMarch 11, 2024
Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse EvBackground: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly used diabetes and obesity medications but have been associated with [...]
March 11, 2024
Gastrointestinal adverse events associated with semaglutide: A pharmacovigilanceSemaglutide was approved for treatment of type 2 diabetes mellitus (T2DM) and chronic weight management in obesity or overweight adults. However, [...]
March 11, 2024
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1This database study examines the association between glucagon-like peptide 1 agonists (eg, semaglutide, liraglutide) used for weight loss and reports of [...]
March 11, 2024
Glucagon-like peptide 1 (GLP-1The glucagon-like peptide-1 (GLP-1) is a multifaceted hormone with broad pharmacological potential. Among the numerous metabolic effects of GLP-1 are the [...]
March 11, 2024
Off-label antiobesity treatment in patients without diabetes with GLP-1 agonistsThe aim of the work was to investigate whether continuation of treatment, side effects, and effect on weight loss of GLP-1 agonists in obese patients [...]
March 1, 2024
A pilot study of chlormequat in food and urine from adults in the United StatesChlormequat chloride is a plant growth regulator whose use on grain crops is on the rise in North America. Toxicological studies suggest that exposure to [...]
February 22, 2024
Intake and adequacy of the vegan diet. A systematic review of the evidence.Background: Vegan diets, where animal- and all their by-products are excluded from the diet, have gained popularity, especially in the last decade. [...]
February 22, 2024
Nicotinamide is a potent inhibitor of proinflammatory cytokines.The present study investigates the modulating effects of nicotinamide on the cytokine response to endotoxin. In an in vitro model of endotoxaemia, human [...]
February 22, 2024
Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent DeacetylatiThis study investigated the effect of nicotinamide (NAM) supplementation on the development of brain inflammation and microglial activation in a mouse [...]
